阿司匹林减少小鼠结直肠肿瘤发生,肠道微生物降低其生物利用度和化学预防效果
研究用APCmin/+小鼠和氧化偶氮甲烷/葡聚糖硫酸钠诱导的结直肠癌模型,发现阿司匹林减少结直肠肿瘤数量和负荷依赖于肠道微生物的存在。肠道需氧菌如球形赖氨酸芽孢杆菌可降解阿司匹林,降低其血浆水平和化学预防效果。
要点
- 阿司匹林减少结直肠肿瘤的作用依赖于肠道微生物的存在。
- 球形赖氨酸芽孢杆菌降解阿司匹林,降低其血浆水平和化学预防效果。
- 阿司匹林喂养小鼠粪便中有益菌双歧杆菌和乳杆菌富集,致病菌减少。
核心结论
- 阿司匹林减少APCmin/+小鼠和氧化偶氮甲烷/葡聚糖硫酸钠处理小鼠的结直肠肿瘤发生,该作用依赖于肠道微生物的存在。
- 肠道中的球形赖氨酸芽孢杆菌降解阿司匹林并降低其在小鼠中的化学预防效果。
- 阿司匹林喂养小鼠的粪便样本中有益菌富集,致病菌减少。
研究设计与样本
- 研究使用APCmin/+小鼠和给予氧化偶氮甲烷与葡聚糖硫酸钠诱导结直肠癌发生的小鼠进行实验。
- 部分小鼠在整个实验期间给予抗生素以清除肠道微生物,联合或不联合阿司匹林。
- 无菌小鼠用于验证实验。
- 结肠组织进行组织病理学、定量逆转录聚合酶链反应和免疫印迹分析。
- 血样和肠腔内容物进行液相色谱/质谱分析和芳基酯酶活性测定。
主要发现
- 阿司匹林减少给予抗生素(肠道微生物清除)的APCmin/+小鼠和氧化偶氮甲烷/葡聚糖硫酸钠处理小鼠的结直肠肿瘤数量和负荷,但在肠道微生物完整的小鼠中未减少。
- 给予阿司匹林的无菌小鼠比给予阿司匹林的常规化无菌小鼠发生的结直肠肿瘤更少。
- 给予抗生素的小鼠血浆阿司匹林水平高于肠道微生物完整的小鼠。
- 肠腔内容物分析显示需氧肠道微生物包括球形赖氨酸芽孢杆菌降解阿司匹林。
- 喂饲球形赖氨酸芽孢杆菌的无菌小鼠血浆阿司匹林水平低于未喂饲该细菌的无菌小鼠。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Alterations in the intestinal microbiota affect development of colorectal cancer and drug metabolism. We studied whether the intestinal microbiota affect the ability of aspirin to reduce colon tumor development in mice. METHODS: We performed studies with APCmin/+ mice and mice given azoxymethane and dextran sulfate sodium to induce colorectal carcinogenesis. Some mice were given antibiotics to deplete intestinal microbes, with or without aspirin, throughout the entire experiment. Germ-free mice were studied in validation experiments. Colon tissues were collected and analyzed by histopathology, quantitative reverse-transcription polymerase chain reaction, and immunoblots. Blood samples and gut luminal contents were analyzed by liquid chromatography/mass spectrometry and an arylesterase activity assay. Fecal samples were analyzed by 16S ribosomal RNA gene and shotgun metagenome sequencing. RESULTS: Administration of aspirin to mice reduced colorectal tumor number and load in APCmin/+ mice and mice given azoxymethane and dextran sulfate sodium that had been given antibiotics (depleted gut microbiota), but not in mice with intact microbiota. Germ-free mice given aspirin developed fewer colorectal tumors than conventionalized germ-free mice given aspirin. Plasma levels of aspirin were higher in mice given antibiotics than in mice with intact gut microbiota. Analyses of luminal contents revealed that aerobic gut microbes, including Lysinibacillus sphaericus, degrade aspirin. Germ-free mice fed L sphaericus had lower plasma levels of aspirin than germ-free mice that were not fed this bacterium. There was an inverse correlation between aspirin dose and colorectal tumor development in conventional mice, but this correlation was lost with increased abundance of L sphaericus. Fecal samples from mice fed aspirin were enriched in Bifidobacterium and Lactobacillus genera, which are considered beneficial, and had reductions in Alistipes finegoldii and Bacteroides fragili, which are considered pathogenic. CONCLUSIONS: Aspirin reduces development of colorectal tumors in APCmin/+ mice and mice given azoxymethane and dextran sulfate sodium, depending on the presence of intestinal microbes. L sphaericus in the gut degrades aspirin and reduced its chemopreventive effects in mice. Fecal samples from mice fed aspirin were enriched in beneficial bacteria, with reductions in pathogenic bacteria.
引用
- Zhao R, Coker OO, Wu J, et al. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects. Gastroenterology. 2020. PMID: 32387495. doi:10.1053/j.gastro.2020.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。